Repligen

Repligen Corporation is a global life sciences company that specializes in bioprocessing technologies for biologic drug manufacturing. Founded in 1981 by pioneering scientists, the company is headquartered in Waltham, Massachusetts, and operates worldwide with facilities in the U.S., Europe, and Asia. Repligen develops consumable products and systems that enhance the production of biological drugs.The company's product portfolio includes upstream and downstream bioprocessing technologies such as filtration systems, chromatography products, fluid management solutions, and cell culture supplements. Repligen also offers technical services, including installation, calibration, and custom bioprocessing solutions. Its technologies are essential for manufacturing monoclonal antibodies, gene therapies, and vaccines, serving biopharmaceutical developers and contract development and manufacturing organizations globally.Repligen has expanded its capabilities through strategic acquisitions and partnerships, focusing on innovation to meet the growing demand for biologics. The company aims to be a trusted partner in bioprocessing, helping to reduce costs and timelines for biologic drug development while ensuring compliance with regulatory standards.